Results 181 to 190 of about 100,641 (375)

Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease [PDF]

Mezin Öthman, Filip Bergquist, Per Odin, Monica Scharfenort, Anders Johansson, Ioanna Markaki, Per Svenningsson, Nil Dizdar, Dag Nyholm   +8 more
openalex   +1 more source

Study of Safety and Effectiveness of Levodopa in Patients with Parkinson’s Disease

, 2022
Bayan Ali, Emad Fadel, Hani Basilim, Omar Alsaeidi, Mervat Abdullah Baraja, Bandari Saad Albishi, Zahra Al Radi, Mohammed A. Assiri, Mooza Abusaif, Iman Aldebasi, Fahad Harshan, Bayader Alsalem   +11 more
openalex   +1 more source

A review of neuroleptic malignant syndrome : incidence and features in Malta [PDF]

, 1995
This paper describes Malta’s first sample of Neuroleptic Malignant Syndrome (NMS) and reviews the current literature. A retrospective sample of all diagnosed cases of NMS was reviewed using Pope’s (1986) criteria. Twelve cases were identified yielding an
Grech, Anton, Saliba, Joseph R.
core  

Brain Imaging Changes Following Deep Brain Stimulation Patients with Parkinson's Disease: A Literature Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as tremors, rigidity, and bradykinesia. Structural brain changes, including atrophy in the midbrain, basal ganglia, and cortical regions such as the frontal and temporal lobes, are observed in advanced stages.
Suraiya Mangra, Stanislaw Szlufik, Chao‐Kai Hu, Alexandre Boutet, Jürgen Germann, Andres M. Lozano   +5 more
wiley   +1 more source

Corrigendum to “Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes” [Parkinsonism Relat. Disord. 21(3) (2015) 231–235] [PDF]

, 2016
Angelo Antonini, Ashley Yegin, Cornelia Preda, Lars Bergmann, Werner Poewe   +4 more
openalex   +1 more source

Medication Knowledge of Patients with Parkinson's Disease: Strengths and Gaps

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Effective drug treatment of motor and non‐motor symptoms in Parkinson's disease (PD) often requires the administration of several anti‐Parkinson drugs in complex treatment regimens. The successful autonomous application of drugs places high demands on therapy adherence, which in turn relies on sufficient medication knowledge ...
Stephan Greten, Sarana Ulaganathan, Johannes Heck, Lan Ye, Matthias Höllerhage, Christoph Schrader, Corinna Ziemann, Olaf Krause, Florian Wegner, Martin Klietz   +9 more
wiley   +1 more source

Oral Levodopa Therapy, Vitamin B6 and Peripheral Neuropathy: A Cross‐Sectional Observational Study [PDF]

Catherine Déry, Camilla Bakkalia Büchmann, Geneviève Labrecque, Vicky Caron, David Simonyan, Mathieu Blais, Manon Bouchard, Nicolas Dupré   +7 more
openalex   +1 more source

The effect of levodopa on bilateral coordination and gait asymmetry in Parkinson’s disease using inertial sensor [PDF]

, 2021
Minji Son, Seung Hwan Han, Chul Hyoung Lyoo, Joo Ae Lim, Jeanhong Jeon, Kee-Bum Hong, Hoon Park   +6 more
openalex   +1 more source

The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan, Seyed‐Mohammad Fereshtehnejad, Christos Ganos, Emily Swinkin, Anthony E. Lang   +4 more
wiley   +1 more source

Molecular imaging of levodopa-induced dyskinesias

, 2015
Flavia Niccolini, Lorenzo Rocchi, Marios Politis   +2 more
openalex   +2 more sources